Cite
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.
MLA
Tidball, Andrew M., et al. “A Novel Manganese-Dependent ATM-P53 Signaling Pathway Is Selectively Impaired in Patient-Based Neuroprogenitor and Murine Striatal Models of Huntington’s Disease.” Human Molecular Genetics, vol. 24, no. 7, Apr. 2015, pp. 1929–44. EBSCOhost, https://doi.org/10.1093/hmg/ddu609.
APA
Tidball, A. M., Bryan, M. R., Uhouse, M. A., Kumar, K. K., Aboud, A. A., Feist, J. E., Ess, K. C., Neely, M. D., Aschner, M., & Bowman, A. B. (2015). A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington’s disease. Human Molecular Genetics, 24(7), 1929–1944. https://doi.org/10.1093/hmg/ddu609
Chicago
Tidball, Andrew M., Miles R. Bryan, Michael A. Uhouse, Kevin K. Kumar, Asad A. Aboud, Jack E. Feist, Kevin C. Ess, M. Diana Neely, Michael Aschner, and Aaron B. Bowman. 2015. “A Novel Manganese-Dependent ATM-P53 Signaling Pathway Is Selectively Impaired in Patient-Based Neuroprogenitor and Murine Striatal Models of Huntington’s Disease.” Human Molecular Genetics 24 (7): 1929–44. doi:10.1093/hmg/ddu609.